Neurelis Put an Old Seizure Drug in the Nose - and Built a $300 Million Business Around the Hard Part

The medicine was familiar. The delivery problem was not. Neurelis spent more than a decade making diazepam work as a practical nasal rescue treatment - then showed how a narrow patient problem can become a platform, a pipeline and a profitable commercial company.